AP
BSX icon

Arlington Partners’s Boston Scientific BSX Stock Holding History

Arlington Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-34
Closed -$1.84K – 389
2023
Q2 		$1.84K Sell
34
-367
-92% -$19.2K ﹤0.01% 538
2023
Q1 		$20.1K Buy
401
+34
+9% +$1.6K ﹤0.01% 343
2022
Q4 		$17K Buy
+367
New +$15.9K ﹤0.01% 321
2022
Q1 		– Sell
-181
Closed -$8K – 469
2021
Q4 		$8K Buy
+181
New +$7.61K ﹤0.01% 504
2020
Q2 		– Sell
-29
Closed -$1K – 180
2020
Q1 		$1K Buy
+29
New +$1.13K ﹤0.01% 284

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arlington Partners's BSX Position: Q3 2023 in Review

Arlington Partners sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 34 shares — an estimated $1.84K sold.

Arlington Partners first reported a position in BSX in Q1 2020 and held it in 5 quarters. The position peaked at $20.1K in Q1 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Arlington Partners reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Arlington Partners sold 34 Boston Scientific shares in Q3 2023, an estimated $1.84K.
  • Arlington Partners first reported a position in Boston Scientific in Q1 2020 and held it in 5 quarters.
  • Arlington Partners's Boston Scientific position peaked at $20.1K in Q1 2023.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.